Toxicity and Supportive Care Related to Chemotherapy

  • J. A. Maroun
Conference paper


Chemotherapeutic agents for the treatment of cancer characteristically have narrow therapeutic margins leading to significant side effects. Their early recognition and appropriate management are major tasks in today’s cancer treatment. Progress in supportive care has made an important contribution to cancer control over the last two decades. It is useful to discuss chemotherapy toxicity under four categories:
  1. A)

    Immediate and local toxicities

  2. B)

    Early toxicities

  3. C)

    Specific organ toxicities

  4. D)

    Long-term complications



Acute Leukemia Cytotoxic Drug Nitrogen Mustard Bone Marrow Depression Scalp Cool 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Baker, J.J., Lockey, J.L., Price, N.A., Bowen, J., and Winokur, S.H.: Comparison of dexamethasone plus prochlorperazine to placebo plus prochlorperazine as antiemetics for cancer chemotherapy. Proc. Am. Soc. Clin. Oncol. 21, 339, 1980.Google Scholar
  2. 2.
    Bodey, G.P., et al: Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann. Intern. Med. 64, 328, 1966.PubMedGoogle Scholar
  3. 3.
    Bodey, G.P., Rodriguez, V., Chang, H.Y., and Narboin, G.: Fever and infection in leukemic patients. A study of 494 consecutive patients. Cancer 41, 1610, 1978a.PubMedCrossRefGoogle Scholar
  4. 4.
    Bodey, G.P.: Using drugs for the compromised patient: Management of bacterial infections. Drug Therapy 8, 161, 1978b.Google Scholar
  5. 5.
    Canellos, G.P., DeVita, V.T., Arseneau, J.C., Whang, P.J., and Johnson, R.E.C.: Second malignancies complicating Hodgkin’s disease in remission. Lancet i, 947, 1975.CrossRefGoogle Scholar
  6. 6.
    Dean, J.C., Salmon, S.E. and Griffith, K.S.: Prevention of doxorubicininduced hair loss with scalp hypothermia. N. Engl. J. Med. 301, 1427, 1979.PubMedCrossRefGoogle Scholar
  7. 7.
    Dekker, A.W., Rozenberg-Arska, M., Sixma, J.J., and Verhoeff, J.: Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukemia. Ann. Intern. Med. 95, 555, 1981.PubMedGoogle Scholar
  8. 8.
    Dorr, R.T., and Fritz, W.L. (a): Cancer Chemotherapy Handbook, Elsvier, N.Y., pp 116–135.Google Scholar
  9. 9.
    Dorr, R.T. and Fritz, W.L. (b): Cancer Chemotherapy Handbook, Elsvier, N.Y., pp 136–142.Google Scholar
  10. 10.
    Edelstyn, G.A., MacDonald, M., and MacRae, K.D.: Doxorubicin -induced hair loss and possible modification by scalp cooling. Lancet 2, 253, 1977.PubMedCrossRefGoogle Scholar
  11. 11.
    Gralla, R.J., Itri, L.M., Pisko, S.E., et al: Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N. Engl. J. Med. 305, 905, 1981.PubMedCrossRefGoogle Scholar
  12. 12.
    Harris, C.C.: Immunosuppressive anticancer drugs in man: Their oncogenic potential. Radiology 114, 163, 1975.PubMedGoogle Scholar
  13. 13.
    Heriman, T.S., Einhorn, L.H., Jones, S.E., et al: Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy. N. Engl. J. Med. 300, 1295, 1979.CrossRefGoogle Scholar
  14. 14.
    Horning, S.J., Hoppe, R.T., Kaplan, H.S. and Rosenberg, S.A.: Female reproductive potential after treatment for Hodgkin’s disease. N. Engl. J. Med. 304, 1377, 1981.PubMedCrossRefGoogle Scholar
  15. 15.
    Ignoffo, R.J., and Friedman, M.A.: Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs. Cancer Treat. Rev. 7, 17, 1980.PubMedCrossRefGoogle Scholar
  16. 16.
    Karchmer, R.K., Amare, M., Larsen, W.E., Mallouk, A.G., and Caldwell, G.G.: Alkylating agents as leukemogens in multiple myeloma. Cancer 33, 1103, 1974.PubMedCrossRefGoogle Scholar
  17. 17.
    Larson, D.L.: Treatment of tissue extravasation by antitumor agents. Cancer 49, 1796, 1982.PubMedCrossRefGoogle Scholar
  18. 18.
    Lee, B.J.: Methylprednisolone as an antiemetic. N. Engl. J. Med. 304, 486, 1981.PubMedGoogle Scholar
  19. 19.
    Maher, J.: Intravenous lorazepam to prevent nausea and vomiting associated with cancer therapy. Lancet i, 91, 1981.CrossRefGoogle Scholar
  20. 20.
    Moertel, C.G., Reitemeier, R.J., and Gage, R.P.: A controlled clinical evaluation of antiemetic drugs. JAMA 186, 116, 1963.PubMedCrossRefGoogle Scholar
  21. 21.
    Penn, I.: Occurrence of cancer in immune deficiencies. Cancer 34, 858, 1974PubMedCrossRefGoogle Scholar
  22. 22.
    Penn, I.: The incidence of malignancies in transplant recipients. Transpl. Proc. 7, 323, 1975.Google Scholar
  23. 23.
    Penn, I.: Second malignant neoplasms associated with immunosuppressive medications. Cancer 37, 1024, 1976.PubMedCrossRefGoogle Scholar
  24. 24.
    Plotkin, D.A., Plotkin, D., and Okum, R.: Haloperidol in the treatment of nausea and vomiting due to cytotoxic drug administration. Curr. Therap. Res. 15, 599, 1973.Google Scholar
  25. 25.
    Reimen, R.R., Hoover, R., Froumeni, J.F., Jr., and Young, R.C.: Acute leukemia after alkylating-agent therapy of ovarian cancer. N. Engl. J. Med. 297, 177, 1977.CrossRefGoogle Scholar
  26. 26.
    Salan, S.E., Cronim, C., Zelen, M., and Zimberg, N.E.: Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine. N. Engl. J. Med. 302, 135, 1980.CrossRefGoogle Scholar
  27. 27.
    Sherins, R.J., and DeVita, V.T., Jr: Effect of drug treatment for lymphoma on male reproductive capacity. Ann. Int. Med. 79, 216, 1973.PubMedGoogle Scholar
  28. 28.
    Stutzman, L., and Sokal, J.: Use of anticancer drugs during pregnancy. Clin. Obstet. Gynecol. 11, 416, 1968.PubMedGoogle Scholar
  29. 29.
    Weiser, B., Lange, M., Fialk, M.A., et al: Prophylactic trimethoprim sulfamethoxazole during consolidation chemotherapy for acute leukemia: A controlled trial. Ann. Int. Med. 95, 436, 1981.PubMedGoogle Scholar
  30. 30.
    Weiss, R.B., and Bruno, S.: Hypersensitivity reactions to cancer chemotherapeutic agents. Ann. Int. Med. 94, 66, 1981.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • J. A. Maroun

There are no affiliations available

Personalised recommendations